Skip to main content Skip to main navigation menu Skip to site footer

Hemostasis in liver surgery: Indonesian Society of Digestive Surgeons (IKABDI) consensus statements

  • Arnetta Naomi Lalisang ,
  • Adianto Nugroho ,
  • Michael Tendean ,
  • Irwan ,
  • Indah Situmorang ,
  • Julianus A. Uwuratuw ,
  • Tomy Lesmana ,
  • Erik Prabowo ,
  • Adeodatus Y. Handaya ,
  • Agung A. Wibowo ,
  • Maria Mayasari ,
  • Yarman Mazni ,
  • Jeffri ,
  • Bambang Suprapto ,
  • Ahmad F. Fuadi ,
  • Fransiscus Arifin ,
  • Reno Rudiman ,
  • Toar J.M. Lalisang ,
  • Warsinggih ,


Liver resection is a complex operation with bleeding control as one of the most crucial factors. It is essential to determine the amount of bleeding to predict the mortality and morbidity after liver surgery. With technology and scientific development, liver resection can use open or laparoscopic surgical techniques supported by various energy devices and medical management. However, the main goal is to remove the tumor with adequate negative margins and good flow. Indonesian Society of Digestive Surgeons agreed to have an agreement using the Modified Delphi method consisting of twenty digestive surgeons. The consensus was established for hemostasis management choices as surgical and medical strategies in liver surgery. The surgical strategies recommendation include performing anatomical resection in primary hepatic tumor and non-anatomical resection for liver metastases; using of Glissonean Pedicle approach as an inflow control option; doing routine intermittent pringle maneuvers; prohibiting total vascular exclusion; and making a statement that no particular energy device preferred for transecting the liver parenchyma. For medical strategies, consensus recommends limiting the transfusion of PRC or any other blood components, antifibrinolytic's role as hemostatic agents, and using fibrin sealant and matrix coagulant sheets for hemostatic agents in liver surgery. These recommendations reflect current knowledge and can be reviewed if new findings are discovered. Hopefully, this consensus can be a valuable guide for surgeons, especially those practicing in Indonesia, to provide low mortality and morbidity in liver resection.


  1. Lortat-jacob JL and Robert HG. Well defined technic for right hepatectomy. Presse Med, 1952: 60(26); 549–51.
  2. Dimitroulis D. Indications, limitations and maneuvers to enable extended hepatectomy: Current trends. World J Gastroenterol. 2014;20(24):7887, doi: 10.3748/wjg.v20.i24.7887
  3. Eeson G, Karanicolas PJ. Hemostasis and hepatic surgery. Surg Clin N Am. 2016; 96(2); 219-28, doi: 10.1016/j.suc.2015.12.001.
  4. Romano F. Bleeding in hepatic surgery: Sorting through methods to prevent it. HPB Surg, 2012:1-12. doi: 10.1155/2012/169351.
  5. Yoh T., Cauchy F., and Soubrane O. Techniques for laparoscopic liver parenchymal transection. Hepatobiliary Surg Nutr. 2019; 8(6):572–581. doi: 10.21037/hbsn.2019.04.16.
  6. Singh S, Gowda SM and Kumar S. Techniques and Energy Sources for Liver Resection: When and How? Open Access Journal of Cancer & Oncology. 2018;2(1). doi: 10.23880/OAJCO-16000117.
  7. Aragon RJ and Solomon NL. Techniques of hepatic resection. J Gastrointest Oncol. 2012; 3(1); 28–40. doi: 10.3978/j.issn.2078-6891.2012.006.
  8. Lee CW. Risk factors for early mortality after hepatectomy for hepatocellular carcinoma. Medicine. 2016; 95(39); 5028. doi: 10.1097/MD.0000000000005028.
  9. T. Yang, J. Zhang, J.-H. Lu, G.-S. Yang, M.-C. Wu, and W.-F. Yu. Risk Factors Influencing Postoperative Outcomes of Major Hepatic Resection of Hepatocellular Carcinoma for Patients with Underlying Liver Diseases. World J Surg. 2011; 35(9); 2073–2082. doi: 10.1007/s00268-011-1161-0.
  10. E. Benzoni. Liver resection for HCC: analysis of causes and risk factors linked to postoperative complications. Hepatogastroenterology.2007; 54(73);186–9.
  11. Abu Hilal M, Aldrighetti L, Dagher I, Edwin B, Troisi RI, Alikhanov R. The Southampton Consensus Guidelines for Laparoscopic Liver Surgery: From Indication to Implementation. Ann Surg. 2018;268(1):11-8.
  12. H. Liu, F.-J. Hu, H. Li, T. Lan, and H. Wu. Anatomical vs nonanatomical liver resection for solitary hepatocellular carcinoma: A systematic review and meta-analysis. World J Gastrointest Oncol.2021; 13(11); 1833–1846. doi: 10.4251/wjgo.v13.i11.1833.
  13. R. Matsuki, Y. Mise, A. Saiura, Y. Inoue, T. Ishizawa, and Y. Takahashi. Parenchymal-sparing hepatectomy for deep-placed colorectal liver metastases. Surgery.2016: 160(5): 1256–1263. doi: 10.1016/j.surg.2016.06.041.
  14. M. Matsumura. Parenchymal-Sparing Hepatectomy Does Not Increase Intrahepatic Recurrence in Patients with Advanced Colorectal Liver Metastases. Ann Surg Oncol. 2016; 23(11):3718–3726. doi: 10.1245/s10434-016-5278-0.
  15. S. Okumura. Laparoscopic Parenchymal-Sparing Hepatectomy for Multiple Colorectal Liver Metastases Improves Outcomes and Salvageability: A Propensity Score-Matched Analysis. Ann Surg Oncol. 2019: 26(13); 4576–4586. doi: 10.1245/s10434-019-07902-x.
  16. D. Moris. Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review. Journal of Gastrointestinal Surgery.2017; 21(6);1076–1085. doi: 10.1007/s11605-017-3397-y.
  17. G. Deng. Parenchymal‐sparing versus extended hepatectomy for colorectal liver metastases: A systematic review and meta‐analysis. Cancer Med, 2019;8(14); 6165–6175. doi: 10.1002/cam4.2515.
  18. Rahbari N. N. Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection. British Journal of Surgery.2008; 95(4); 424–432. doi: 10.1002/bjs.6141.
  19. J. H. Pringle. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg. 1908;48(4); 541–549. doi: 10.1097/00000658-190810000-00005.
  20. K. Man. Tolerance of the Liver to Intermittent Pringle Maneuver in Hepatectomy for Liver Tumors. Archives of Surgery.1999;134(5); 533–539. doi: 10.1001/archsurg.134.5.533.
  21. S. A. Ortiz Galindo. Safety of intermittent Pringle maneuver during minimally invasive liver resection in patients with hepatocellular carcinoma with and without cirrhosis. Langenbecks Arch Surg.2022; 407(1);235–244. doi: 10.1007/s00423-021-02361-z.
  22. N. Lin, J. Li, Q. Ke, L. Wang, and J. Liu. Does intermittent pringle maneuver loss its clinical value in reducing bleeding during hepatectomy? A systematic review and meta-analysis. International Journal of Surgery.2020;81:158–164. doi: 10.1016/j.ijsu.2020.06.034.
  23. J. P. Heaney, W. K. Stanton, D. S. Halbert, J. Seidel, and T. Vice. An Improved Technic for Vascular Isolation of the Liver. Ann Surg.1966;163(2); 237–241. doi: 10.1097/00000658-196602000-00013.
  24. D. Azoulay. Liver resection using total vascular exclusion of the liver preserving the caval flow, in situ hypothermic portal perfusion and temporary porta-caval shunt: a new technique for central tumors. Hepatobiliary Surg Nutr.2014;3(3);149–53. doi: 10.3978/j.issn.2304-3881.2014.05.02.
  25. D. Elias. Intermittent vascular exclusion of the liver (without vena cava clamping) during major hepatectomy. British Journal of Surgery. 2005; 82(11);1535–1539. doi: 10.1002/bjs.1800821126.
  26. S. Mobarak. Selective Hepatic Vascular Exclusion versus Pringle Maneuver in Major Hepatectomy: A Systematic Review and Meta-Analysis. Front Surg.2022;9. doi: 10.3389/fsurg.2022.860721.
  27. M. Li. Selective Hemihepatic Vascular Occlusion Versus Pringle Maneuver in Hepatectomy for Primary Liver Cancer. Medical Science Monitor.2017(23); 2203–2210. doi: 10.12659/MSM.900859.
  28. E. Moggia. Methods to decrease blood loss during liver resection: a network meta-analysis. Cochrane Database of Systematic Reviews. 2016. doi: 10.1002/14651858.CD010683.pub3.
  29. V. Pamecha, K. S. Gurusamy, D. Sharma, and B. R. Davidson. Techniques for liver parenchymal transection: a meta-analysis of randomized controlled trials. HPB (Oxford).2009; 11(4); 275–81. doi: 10.1111/j.1477-2574.2009.00057.x.
  30. N. N. Rahbari. Meta-Analysis of the Clamp-Crushing Technique for Transection of the Parenchyma in Elective Hepatic Resection: Back to Where We Started? Ann Surg Oncol.2009;16(3);630–639. doi: 10.1245/s10434-008-0266-7.
  31. S. K. Kamarajah. A systematic review and network meta-analysis of parenchymal transection techniques during hepatectomy: an appraisal of current randomised controlled trials. HPB. 2020;22(2); 204–214. doi: 10.1016/j.hpb.2019.09.014.
  32. G. Longchamp, I. Labgaa, N. Demartines, and G.-R. Joliat. Predictors of complications after liver surgery: a systematic review of the literature. HPB. 2021; 23(5); 645–655. doi: 10.1016/j.hpb.2020.12.009.
  33. S. Bennett. The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic review. HPB.2017;19(4); 321–330. doi: 10.1016/j.hpb.2016.12.008.
  34. Y. Xun, H. Tian, L. Hu, P. Yan, K. Yang, and T. Guo. The impact of perioperative allogeneic blood transfusion on prognosis of hepatocellular carcinoma after radical hepatectomy. Medicine.2018; 97(43); 12911. doi: 10.1097/MD.0000000000012911.
  35. N. Latchana, D. H. Hirpara, J. Hallet, and P. J. Karanicolas. Red blood cell transfusion in liver resection. Langenbecks Arch Surg.2019;404(1); 1–9. doi: 10.1007/s00423-018-1746-2.
  36. A. Murtha-Lemekhova, J. Fuchs, E. Ritscher, and K. Hoffmann. Effect of Autotransfusion in HCC Surgery on Survival and Recurrence: A Systematic Review and Meta-Analysis. Cancers (Basel).2022;14(19):4837. doi: 10.3390/cancers14194837.
  37. S. Bennett. Ottawa Criteria for Appropriate Transfusions in Hepatectomy. Ann Surg. 2018; 267(4); 766–774. doi: 10.1097/SLA.0000000000002205.
  38. J. Bednarsch. Intraoperative Transfusion of Fresh Frozen Plasma Predicts Morbidity Following Partial Liver Resection for Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery.2021;25(5); 1212–1223. doi: 10.1007/s11605-020-04652-0.
  39. J. Wehry, R. Cannon, C. R. Scoggins, L. Puffer, K. M. McMasters, and R. C. G. Martin. Restrictive blood transfusion protocol in liver resection patients reduces blood transfusions with no increase in patient morbidity. The American Journal of Surgery.2015;209(2);280–288. doi: 10.1016/j.amjsurg.2014.06.016.
  40. A. Koh, A. Adiamah, D. Gomez, and S. Sanyal.Safety and Efficacy of Tranexamic Acid to Minimise Perioperative Bleeding in Hepatic Surgery: A Systematic Review and Meta-Analysis. World J Surg.2022;46(2); 441–449. doi: 10.1007/s00268-021-06355-2.
  41. P. J. Karanicolas. Major liver resection, systemic fibrinolytic activity, and the impact of tranexamic acid.HPB.2016;18(12): 991–999. doi: 10.1016/j.hpb.2016.09.005.
  42. R. Brustia, B. Granger, and O. Scatton. An update on topical haemostatic agents in liver surgery: systematic review and meta analysis. J Hepatobiliary Pancreat Sci. 2016; 23(10): 609–621. doi: 10.1002/jhbp.389.
  43. C. I. Wells. Haemostatic Efficacy of Topical Agents During Liver Resection: A Network Meta-Analysis of Randomised Trials. World J Surg. 2020; 44(10); 3461–3469. doi: 10.1007/s00268-020-05621-z.
  44. H. Ding. Systematic review and meta-analysis of application of fibrin sealant after liver resection. Curr Med Res Opin. 2013;29(4);387–394. doi: 10.1185/03007995.2013.768216.
  45. K. Reddy. Effectiveness of fibrin glue in adherence of skin graft. J Cutan Aesthet Surg.2017; 10(2);72. doi: 10.4103/JCAS.JCAS_100_16.
  46. H. Moldovan. Biomaterials as Haemostatic Agents in Cardiovascular Surgery: Review of Current Situation and Future Trends. Polymers (Basel).2022;14(6);1189. doi: 10.3390/polym14061189.

How to Cite

Lalisang, A. N., Nugroho, A., Tendean, M., Irwan, Situmorang, I., Uwuratuw, J. A., Lesmana, T., Prabowo, E., Handaya, A. Y., Wibowo, A. A., Mayasari, M., Mazni, Y., Jeffri, Suprapto, B., Fuadi, A. F., Arifin, F., Rudiman, R., Lalisang, T. J., & Warsinggih. (2023). Hemostasis in liver surgery: Indonesian Society of Digestive Surgeons (IKABDI) consensus statements. Bali Medical Journal, 12(1), 782–787.